Cardiac resynchronization therapy

David A Kass1

  • 1Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA. dkass@jhmi.edu

Insights

Cardiac resynchronization therapy (CRT) improves heart function in patients with heart failure by addressing discoordinate contractions. This therapy enhances symptoms and reduces mortality by correcting electrical and mechanical delays.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Treatment

Background:

  • Dilated heart failure often presents with discoordinate contractions due to electrical delays.
  • These delays lead to mechanical dyssynchrony between heart walls, impacting overall function.
  • Understanding this pathophysiology is crucial for developing effective treatments.

Purpose of the Study:

  • To review the pathophysiology of cardiac dyssynchrony in heart failure.
  • To examine the effects of cardiac resynchronization therapy (CRT) on heart function and energetics.
  • To assess the chronic efficacy of CRT in improving symptoms and reducing mortality.

Main Methods:

  • Review of existing studies on cardiac dyssynchrony and CRT.
  • Analysis of data on heart function, energetics, symptoms, and mortality in CRT patients.
  • Identification of patient subgroups most likely to benefit from CRT.

Main Results:

  • CRT addresses discoordinate contractions caused by electrical and mechanical delays.
  • Studies show CRT can enhance heart function and energetics.
  • Evidence suggests chronic CRT improves symptoms and reduces mortality in select patients.

Conclusions:

  • Cardiac resynchronization therapy is a valuable treatment for specific heart failure patients.
  • CRT effectively manages cardiac dyssynchrony, leading to improved clinical outcomes.
  • Further research continues to refine patient selection for optimal CRT benefits.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...